We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Collaboration Produces Clone of Endangered Species

By Biotechdaily staff writers
Posted on 16 Apr 2003
Three groups have combined their efforts to successfully clone a wild bovine species from the forests of Southeast Asia, closely related to the domesticated cow. More...
Two banteng clones were born to Angus cows in early April 2003.

The process began with the transfer of genetic material from the cell of one bovine species to another at a laboratory in Massachusetts operated by Advanced Cell Technology, Inc. (ACT, Worcester, USA). Scientists transferred the DNA of frozen banteng skin cells that had been stored in the San Diego (CA, USA) Frozen Zoo into empty eggs from ordinary domestic cows. The embryos were then transferred to the Trans Ova Genetics (Sioux Center, IA, USA) research center in Iowa, where they were implanted into ordinary cows, which gestated the calves.

"The Zoological Society of San Diego founded a genetic bank of frozen tissue samples, known as the Frozen Zoo, more than 25 years ago,” explained Oliver Ryder, Ph.D., geneticist for the society. "At that time, we did not know how this resource might be used, but we knew it was important to save as much information about endangered species as we could.”

Advanced Cell Technology is involved in the research and development of stem cells and therapeutic nuclear transfer technology for the treatment of human disease. Trans Ova Genetics is involved in the collection and nuclear transfer of bovine embryos. Cross-species cloning is a new procedure to be used in the effort to save endangered species and represents an application of genetic technology unavailable until a few years ago.





Related Links:
ACT
Trans Ova

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Multi-Chamber Washer-Disinfector
WD 390
New
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.